---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-279483"
form_type: "8-K"
ticker: "OLMA"
cik: "0001750284"
company_name: "Olema Pharmaceuticals, Inc."
filed_at: "2026-06-23T20:19:56+00:00"
generated_at: "2026-06-23T20:21:07.145282+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Olema shareholders elect directors, approve executive compensation, ratify auditor at 2026 annual meeting

## Summary
- Four Class III directors elected: Bohen (67.5M for), Garland (66.2M), Larson (50.4M), Rappaport (67.3M).
- Advisory vote on executive compensation approved: 68.0M for, 654K against, 15.9K abstain.
- Ernst & Young ratified as independent auditor for FY2026: 75.8M for, 272K against, 52.5K abstain.
- Broker non-votes of 7.5M on director and compensation proposals; none on auditor ratification.

## SEC filing metadata
- accession: 0001193125-26-279483
- form_type: 8-K
- ticker: OLMA
- cik: 0001750284
- company_name: Olema Pharmaceuticals, Inc.
- filed_at: 2026-06-23T20:19:56+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750284/000119312526279483/0001193125-26-279483-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750284/000119312526279483/olma-20260617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-279483
- JSON: https://secwatch.observer/filing/0001193125-26-279483.json
- Plain text: https://secwatch.observer/filing/0001193125-26-279483.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.